Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04570839
Title COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Compugen Ltd
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Chicago Medical Center Chicago Illinois 60637 United States Details
Johns Hopkins University Oncology Center. Baltimore Maryland 21231 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
START Midwest. Grand Rapids Michigan 49503 United States Details
Columbia University New York New York 10032 United States Details
University of Pittsburgh Cancer Center. Pittsburgh Pennsylvania 15232 United States Details
The University of Tennessee WEST Cancer Center. Memphis Tennessee 38138 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
The START Center for Cancer Care. San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from for the field